Words Matter: Decreasing Stigma While Caring For Pregnant People with Substance Use-MOM Program Slide

MOM Program Slide

Pdf Summary

The MOM program, or Medicaid Office of Innovation, Research, and Development, provides funding to Medicaid managed care organizations to offer enhanced case management services to pregnant and postpartum Medicaid participants with opioid use disorder. The program includes several core components:<br /><br />1. Comprehensive Case Management: This involves screening for social determinants of health, joint care plan development, and person-centered goal-setting.<br /><br />2. Care Coordination: Ensuring that participants receive coordinated care from various healthcare providers.<br /><br />3. Health Promotion: Encouraging healthy behaviors and practices to improve overall well-being.<br /><br />4. Individual and Family Supports: Providing assistance and resources to participants and their families.<br /><br />5. Linkages to Community and Support Services: Connecting participants to community-based services that can support their recovery.<br /><br />Participation in the program is voluntary, and sobriety, treatment, and medication for opioid use disorder are not requirements for participation. Screenings and care plans are stored in CRISP (Chesapeake Regional Information System for our Patients) and are available to empaneled providers.<br /><br />The program encourages a "no-wrong door referral" approach, meaning that any healthcare provider or individual can refer a pregnant or postpartum Medicaid participant with opioid use disorder to the MOM program for case management services.<br /><br />For more information about the MOM program, including contact information for general inquiries, specific information for consumers and providers, and a self-referral link, visit the Maryland Health Department's website.

Keywords

MOM program

Medicaid Office of Innovation

case management services

opioid use disorder

care coordination

health promotion

community support services

voluntary participation

screenings

CRISP